Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Firefly Neuroscience Inc AIFF

Firefly Neuroscience, Inc. is an artificial intelligence (AI) technology company dedicated to developing neuroscientific solutions that enhance outcomes for patients with mental illnesses and neurological disorders. The Company has developed its FDA-510(k) cleared Brain Network Analytics (BNA) software platform (the BNA Platform) and is focused on advancing diagnostic and treatment approaches... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (NDAQ:AIFF)

Firefly Neuroscience Appoints Current Board Member, Greg Lipschitz, as Executive Chairman

GlobeNewswire 12 hours ago

Firefly Neuroscience Reports Third Quarter 2024 Results and Provides Stockholder Update

GlobeNewswire November 14, 2024

Firefly Neuroscience to Participate in the 8th Annual Florida Capital Event

GlobeNewswire November 6, 2024

Firefly Neuroscience Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire October 25, 2024

Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy for Full Analysis of EEG Data

GlobeNewswire October 21, 2024

Firefly Neuroscience Collaborates with Bright Minds Biosciences to Analyze the Data from its Positive Phase 1 Study using its Artificial Intelligence, FDA-Cleared BNA(TM) Technology

GlobeNewswire October 16, 2024

Firefly Neuroscience Announces Use of Its Brain Network Analytics Platform in Phase 1 Study of SP-624, the First Potential Treatment Designed for Women with Major Depressive Disorder

GlobeNewswire October 15, 2024

Firefly Neuroscience to Participate in Upcoming October Investor Conferences

GlobeNewswire October 11, 2024

Firefly Neuroscience Advances AI-Driven BNA(TM) Technology in Neuroscience Drug Development after Completing Successful Research Collaborations with Takeda and Novartis

GlobeNewswire September 20, 2024

Opinion & Analysis (NDAQ:AIFF)

No current opinion is available.

Bullboard Posts (NDAQ:AIFF)

Expected earnings - Firefly Neuroscience Inc.

NEWS: $AIFF Expected earnings - Firefly Neuroscience Inc.Firefly Neuroscience Inc. (AIFF) is expected to report for Q3 2024AIFF...
whytestocks - November 11, 2024

RE:RE:AIFF.... relative low volume on the way up yesterday &

Yes you're reading the NR correctly.....thats the O/S share total after the merger. What has caught your interest in this U.S listed...
Iseneschal - October 24, 2024

RE:AIFF.... relative low volume on the way up yesterday &

Am I reading the OSS around 8 million?
JWING17 - October 18, 2024

AIFF.... relative low volume on the way up yesterday &

Low volume on the retracement today ; ) I just bot a starter position here ....20 mins before the close Ya pays yo money & yo takes...
Iseneschal - October 17, 2024

AIFF.... Looks like there's a Financing planned

Coin toss....could be good....could be the end Trading at $3.60 during AH
Iseneschal - October 16, 2024

AIFF....NR collaborating with DRUG

Wow....this should be real interesting It should rip
Iseneschal - October 16, 2024